Page 183 - Vitamin D and Cancer

170 E. Gocek and G.P. Studzinski

119. Gonzalez EA, Disthabanchong S, Kowalewski R, Martin KJ (2002) Mechanisms of the
regulation of EGF receptor gene expression by calcitriol and parathyroid hormone in UMR
106–01 cells. Kidney Int 61:1627–1634
120. Schedlich LJ, Muthukaruppan A, ÓHan MK, Baxter RC (2007) Insulin-like growth factor
binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D
response in osteoblasts. Mol Endocrinol 21:2378–2390
121. Lu X, Farmer P, Rubin J, Nanes MS (2004) Integration of the NFkappaB p65 sub-
unit into the vitamin D receptor transcriptional complex: identification of p65
domains that inhibit 1, 25-dihydroxyvitamin D3-stimulated transcription. J Cell Biochem
92:833–848
122. Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha, 25-dihydroxyvitamin D3 sup-
presses proliferation and immunoglobulin production by normal human peripheral blood
mononuclear cells. J Clin Invest 74:657–661
123. Tsoukas CD, Provvedini DM, Manolagas SC (1984) 1, 25-dihydroxyvitamin D3: a novel
immunoregulatory hormone. Science 224:1438–1440
124. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T (1981)
Differentiation of mouse myeloid leukemia cells induced by 1 alpha, 25-dihydroxyvitamin
D3. Proc Natl Acad Sci USA 78:4990–4994
125. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T (1982) 1 alpha,
25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J
204:713–719
126. Studzinski GP, Bhandal AK, Brelvi ZS (1985) A system for monocytic differentiation of
leukemic cells HL 60 by a short exposure to 1, 25-dihydroxycholecalciferol. Proc Soc Exp
Biol Med 179:288–295
127. Munker R, Norman A, Koeffler HP (1986) Vitamin D compounds. Effect on clonal prolifera-
tion and differentiation of human myeloid cells. J Clin Invest 78:424–430
128. Brackman D, Lund-Johansen F, Aarskog D (1995) Expression of cell surface antigens during
the differentiation of HL-60 cells induced by 1, 25-dihydroxyvitamin D3, retinoic acid and
DMSO. Leuk Res 19:57–64
129. Uphoff CC, Drexler HG (2000) Biology of monocyte-specific esterase. Leuk Lymphoma
39:257–270
130. Steiner M, Priel I, Giat J, Levy J, Sharoni Y, Danilenko M (2001) Carnosic acid inhibits
proliferation and augments differentiation of human leukemic cells induced by 1, 25-dihy-
droxyvitamin D3 and retinoic acid. Nutr Cancer 41:135–144
131. Sharabani H, Izumchenko E, Wang Q, Kreinin R, Steiner M, Barvish Z, Kafka M, Sharoni
Y, Levy J, Uskokovic M, Studzinski GP, Danilenko M (2006) Cooperative antitumor effects
of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.
Int J Cancer 118:3012–3021
132. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for
complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433
133. Hickstein DD, Ozols J, Williams SA, Baenziger JU, Locksley RM, Roth GJ (1987) Isolation
and characterization of the receptor on human neutrophils that mediates cellular adherence.
J Biol Chem 262:5576–5580
134. Studzinski GP, Rathod B, Wang QM, Rao J, Zhang F (1997) Uncoupling of cell cycle arrest
from the expression of monocytic differentiation markers in HL60 cell variants. Exp Cell Res
232:376–387
135. Ji Y, Kutner A, Verstuyf A, Verlinden L, Studzinski GP (2002) Derivatives of vitamins D
2
and D3 activate three MAPK pathways and upregulate pRb expression in differentiating
HL60 cells. Cell Cycle 1:410–415
136. Sikora E, Grassilli E, Bellesia E, Troiano L, Franceschi C (1993) Studies of the relationship
between cell proliferation and cell death. III. AP-1 DNA-binding activity during concanavalin
A-induced proliferation or dexamethasone-induced apoptosis of rat thymocytes. Biochem
Biophys Res Commun 192:386–391